SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Holdings

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dodger2 who wrote (9)1/31/1997 12:13:00 PM
From: Robin Peterson   of 224
 
Hi Darrin, I was sitting on the bid at $1.60 anticipating the same usual indifference or incredulity about BIO's release, and BIO has had runs like this before, but I'm wondering if I'll be able to buy any more stock at that level, because there are too many events on the near term horizon for impatience in the investing public to set in.
Ignoring the merits of Diab II for a moment - as you know I have always focused on the fundamentals rather than the market cap - BIO will have to get a CAN$4.00 share price for 3 months(!) in order to
qualify for their NASDAQ Small Cap Listing (after form 20F requirements met).

Whereas people just discovering this story are impressed by momentum, the market is only now reacting to news available before Xmas. It's weird to see the price suddenly jump like this. But much too early to consider selling from my point of view. It's not like it's some mining scam, hyped up on non-existent assets. BIO really believe they have a new superior type II Diabetes drug.

Keep in touch, Robin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext